Vous êtes sur la page 1sur 37

Most frequent GMP deficiencies observed in sterile production facilities

Ian Thrussell, MHRA, UK

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors, Nanjing, November 2009

Session Outline
Inspection Findings - Aseptic Processing
Inspection Findings Terminally sterilised Products Questions

2|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed processes


Materials transferred into Aseptic area with insufficient sterility assurance
Personnel Validated processes Procedures

Poor transfer of partially stoppered vials to lyophiliser Excessive holding times for sterile equipment or filtered solutions

Raw Materials Equipment

Packing Materials

Environment
Premises

3|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed processes


Single filtration
Personnel

Filtration not performed as close as practicable to the filling point Inadequate response to leaking containers no limits set to prompt an investigation

Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

4|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

What happened when these filters are vented!

5|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed processes


Raw material suppliers not audited but acceptance of side samples e.g. sterile API side samples accepted with no justification Prefilled syringe assembly sterilisation sites never audited
Personnel Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

6|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poor clean room and aseptic practices


Filling needles installed & left unprotected while remainder of line set up still taking place Not routinely recorded/documented No monitoring during equipment set up Allowed interventions into aseptic zone are not derived from risk based process review Systems/Procedures not clear what to do upon intervention Interventions not linked to batch release process Packing Materials Raw Materials Equipment Personnel Validated processes Procedures

Environment
Premises

7|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poor clean room and aseptic practices


Interventions not linked to batch release process Excessive numbers of manipulations
Validated processes Procedures Personnel

Excessive numbers of people


People routinely located in the class A zone Failure to use isolation and closed techniques

Raw Materials Equipment

Packing Materials

Environment
Premises

8|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Any intervention or stoppage during an aseptic process can increase the risk of contamination. The design of equipment used in aseptic processing should limit the number and complexity of aseptic interventions by personnel.
Even successfully qualified systems can be compromised by poor operational, maintenance, or personnel practices.

9|

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Aseptic processing operator touches floor when picking up settle plates, sanitizes hands, and then performs intervention immediately afterward
Operator removes sterile forceps from aseptic processing zone (Class 100), carries them through the surrounding Class 10,000 area, and places them on a trolley in the class 10,000 room. These were the only sterile forceps sterilized and available for aseptic manipulations. Later, the operator retrieves forceps and uses them again at the aseptic processing line to manipulate sterile product.
10 |
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or maintained equipment


Viewing ports on sterilising tunnels not adequately sealed Lyophilisers not sterilisable or not sterilised sufficiently frequently
Personnel Validated processes Procedures

Raw Materials Equipment

Vial capping performed under uncontrolled conditions

Packing Materials

Environment
Premises

11 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Construction activities
Major construction in cleanroom next to personnel entry airlock (e.g., gowning).
Construction occurred over approximately one-month period and coincided with continued production

Media Fill Failure 2 weeks later


Construction not considered to be the cause. Root causes identified by investigation considered corrected.

New Media Fill performed Second Media Fill Failure Occurred Contamination attributed to construction
12 |
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Examples of misplaced stoppers from real case lines

13 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Vision systems for raised stopper detection

14 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or maintained equipment Blow fill seal machine


Cooling water Chills mold plates used to form the container-closure into which the sterile drug is filled. Demineralized potable water. Held in tank, chilled (when sampled, yields very high microbial counts) Sterility failure and media fill failure

Personnel Validated processes Procedures

Pseudomonas, sp. and Acinetobacter, sp. found in media fill Stenotrophomonas maltophilia identified as Sterility Failure isolate
Several lots rejected

Raw Materials Equipment

Both the sterility failure and media fill failure attributed to cooling water contamination Root cause of non-sterility was leak/s/ in aseptic filling machines mold plates. Cooling water directly contaminated product. CAPA Issue: Exact date of problem occurrence unknown.

Packing Materials

Environment
Premises

15 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or executed PM monitoring


Samples points inappropriately positioned Alarm systems do not feedback to filling operators. Alarms and procedures unclear and confused
Personnel Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

16 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or executed PM monitoring


Length of tubing to particle counter too long & even kinked! PMS data not reviewed as part of batch release process Overseas-use of manifold systems and no 5 micron monitoring
Personnel Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

17 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or executed PM monitoring


Reliance on the use of contact plates and no use of swabs Reliance on active air monitoring and inadequate use of settle plates Averaging into compliance inadequate attention to the individual high count
Validated processes Procedures Personnel

Raw Materials Equipment

Acceptance of good pattern of very low contamination and failure to evaluate whether the programme is effective.

Packing Materials

Environment
Premises

18 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Poorly designed or executed micro monitoring


Viable sample points not close to point of fill The whole process is not monitored Viable sampling does not cover all key areas under Grade A e.g. vial turntable, stopper hopper Monitoring is not risked based and too routine High pre-filtration bioburden not adequately investigated and bioburden limits >> 10cfu/100ml and no justification
Packing Materials Validated processes Procedures Personnel

Raw Materials Equipment

Environment
Premises

19 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Media fills!
The belief that some contamination is OK! Acceptance criteria does not meet Annex 1 & allows 1 failure to be accepted with no effective investigation Personnel Validated processes Procedures

Poor practices accepted as covered & justified by passing Media Fills!


Good history does not mean failures/growth need not be investigated Implications to batches on the market or in stock subsequent to failures are not always considered fully

Raw Materials Equipment

Packing Materials

Environment
Premises

20 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Media fills!
Interventions allowed in procedures but not covered by simulations Excessive interventions not prohibited
Personnel Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

21 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Steam Sterilisation!
Leak test/Bowie Dick test not performed sufficiently frequently on equipment sterilisers and failures fully investigated. Poor control of checking acceptability of autoclave cycles Engineering work not recorded No trial runs after major breakdowns to show autoclave still meets validated parameters
Packing Materials Personnel Validated processes Procedures

Raw Materials Equipment

Environment
Premises

22 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Steam Sterilisation!
Long heat times during validation not investigated as no limits for heat up times = potential sterility issues
Personnel Validated processes Procedures

Raw Materials Equipment

Packing Materials

Environment
Premises

23 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

When sterilising equipment and components there is just one objective

TO KNOW UNEQUIVOCALLY THAT ALL PARTS OF THE LOAD ARE SUBJECT TO DRY SATURATED STEAM AT THE REQUIRED TEMPERATURE FOR THE REQUIRED TIME.

24 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Gravity Displacement Process


A sterilization process based on the principle that cold air within the chamber is heavier than the steam entering and will sink to the bottom of the chamber. As steam enters the chamber, air is pushed out the bottom drain and exits, with the condensate, through a steam trap.

25 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Equilibration Time
The equilibration time is the period that elapses between attainment of the minimum specified sterilizing temperature in the chamber (chamber reference temperature - typically in the drain) and attainment of the minimum specified sterilization temperature in the load, as measured by the slowest-to-heat penetration probe. This period is an indication of the ability to properly condition the load through air removal and load heating.

26 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Sterilization Process Development

Equilibration Time

27 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

1 Prevacuum - Tyvek Wrapped Materialsl

TC1 Drain

125 124 123 122 121 120 119 118 117 116 115 114 113 112 111 110

TC 5 TC 6 TC 7 TC 8

TC 9
TC 10

Deg C

TC 11
TC 12 TC 13 TC 15 TC 16

TC 17
TC 18

Time

28 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Short equilibration times can be achieved with appropriate pre-vacuums to pre-condition (remove air and heat) the load.
With appropriate load preconditioning, any surface temperature measurement method should yield acceptable results.

With minimal load pre-conditioning, the heat penetration probes covered with autoclave tape were influenced the most.
29 |
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Pre-vacuum Process
A sterilization process in which air is removed from the chamber using a vacuum pump or other mechanical system before the exposure phase begins. This method is particularly suited to load items that can trap air such as tubing, filters and filling machine assemblies.

30 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Steam Sterilisation & SIP systems!


Air removal from equipment not adequately considered Steam quality not assessed adequately
Validated processes Procedures Personnel

Non-condensable gases Wet steam (Dryness Raw Materials fraction) Superheat Clean steam quality tests are not performed at distal points of the distribution system. Packing Materials Steam quality test not performed following modifications Premises

Equipment

Environment

31 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Oven designs!
No overpressure in hot air ovens No HEPA filters on the exhaust side of the oven
Validated processes Procedures Personnel

Raw Materials Equipment

Packing Materials

Environment Premises

32 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Packaging and post sterilisation damage!


Failure to meet GMP: Rough handling of bulk finished vials resulted in difficult to detect and hairline cracks in bottle. Washdown of vials with potable water was apparent contamination source. Patients Infected: multiple blood cultures yield Enterobacter cloacae. At least one lot directly implicated in septicemia Over 25 Septicemia Reports naming the lot or unknown

Personnel Validated processes Procedures

Raw Materials Equipment

Class 1 Recall: Eleven Lots (strong likelihood that product will cause serious adverse health consequences or death)
Cultures of unopened vials grew Enterobacter cloacae

Packing Materials

Environment Premises

Several water samples collected at firm from the water hose/sink found Enterobacter cloacae
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

33 |

Sterile API unacceptable process design!


Huge Grade A/B roomspoor differential pressures Masses of pipe work Redundant equipment Cracks, crevices, ledges.
Packing Materials Raw Materials Equipment Personnel Validated processes Procedures

Sterility starts here!


Premises

Environment

34 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Bulk lyophilisation

35 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Risk of contamination

Extent of human manipulation of sterilised filtrate and lyophilisate during loading and unloading of the large number of trays typically used in these processes. Extent of exposure of sterilised filtrate to controlled environmental conditions during filling, lyophilisation and unloading of lyophiliser compared to lyophilisation in the final container. Extent of aseptic operations subsequent to the sterilisation step at both drug substance and finished product manufacturer in the open tray process compared to lyophilisation in the final container.
Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

36 |

Orchid Video E:\Training Materials\Bulk Lyophilisation Videos\Bulk Lyophilisation\Orchid videos\LYO Unloading - 3 (Frames 2126).mpg

Qilu Video E:\MHRA BAck ups\MHRA Laptop back ups\16_11_09\MHRA Documents\Qilu Autoloading\Video for unloading20081210160000[4].dav

37 |

Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors Nanjing, November 2009

Vous aimerez peut-être aussi